Showing results (2371-2380 of 2,541) with videos related to

Sort By:
Pageof 255
Nature Genetics|December 1, 1996
Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosisI Perrault, J M Rozet, P Calvas, et al.
Scientific Reports|May 6, 2017
Optical coherence tomography-based contact indentation for diaphragm mechanics in a mouse model of transforming growth factor alpha induced lung diseaseKimberley C W Wang, Chrissie J Astell, Philip Wijesinghe, et al.
The Review of Scientific Instruments|January 30, 2021
A new instrument for kinetics and branching ratio studies of gas phase collisional processes at very low temperaturesO Durif, M Capron, J P Messinger, et al.
Leukemia|July 10, 2012
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemiaF J Giles, R T Swords, A Nagler, et al.
The International Journal of Eating Disorders|September 18, 2007
Classification of child and adolescent eating disturbances. Workgroup for Classification of Eating Disorders in Children and Adolescents (WCEDCA)T Bravender, R Bryant-Waugh, D Herzog, et al.
American Journal of Human Genetics|August 21, 2024
Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesisNil Aygün, Celine Vuong, Oleh Krupa, et al.
The Lancet Regional Health. Western Pacific|December 3, 2024
Socioeconomic disadvantage and polygenic risk of overweight in early and mid-life: a longitudinal population cohort study spanning 12 yearsJessica A Kerr, Dorothea Dumuid, Marnie Downes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2019
Metabolomics and microbial composition increase insight into the impact of dietary differences in cirrhosisI Jane Cox, Ramazan Idilman, Andrew Fagan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 2, 2016
Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signalingSwathi Balaji, Xinyi Wang, Alice King, et al.
Haematologica|February 18, 2014
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice dailyTimothy P Hughes, Andreas Hochhaus, Hagop M Kantarjian, et al.
Pageof 255